Edward Wright will become president of CSL Behring Japan. He previously served as general manager and president of Clinigen’s Japanese subsidiary and was also responsible for its South Korean business.
CSL Behring Japan announced that Edward Wright will become president as of 20XX年XX月XX日. His appointment is expected to become official on that date, and he will lead the management of the Japanese subsidiary as its head.
In his previous role, Wright served as general manager and president of Clinigen’s Japanese subsidiary and was also responsible for its South Korean business. His career includes senior positions in specialty care, business development and alliance management at Bayer and Novartis.
Wright has more than 20 years of experience in the pharmaceutical industry, government agencies and the financial sector, as well as knowledge of Japan’s healthcare system and its policy and regulatory environment. He holds a bachelor’s degree in chemistry from the University of Oxford, a PhD in chemistry from the University of Cambridge, an MBA from INSEAD and a bachelor’s degree in international relations from the London School of Economics.